We are live on
!
Find out more
PC
PointState Capital Portfolio holdings
AUM
$7.9B
1-Year Est. Return
42.31%
This Fund
S&P 500
This Quarter
Est. Return
+7.4%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$4.85B
AUM Growth
+$1.14B
(+31%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
22.01%
Top 10 Holdings %
Top 10 Hldgs %
53.88%
Holding
153
New
63
Increased
23
Reduced
14
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$356M |
| 2 |
Amazon
AMZN
|
+$325M |
| 3 |
Broadcom
AVGO
|
+$218M |
| 4 |
MON
Monsanto Co
MON
|
+$163M |
| 5 |
Constellation Brands
STZ
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$371M |
| 2 |
AGN
Allergan plc
AGN
|
+$207M |
| 3 |
Cheniere Energy
LNG
|
+$195M |
| 4 |
Charter Communications
CHTR
|
+$153M |
| 5 |
McDonald's
MCD
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.94% |
| 2 | Energy | 13.27% |
| 3 | Communication Services | 10.39% |
| 4 | Technology | 9.49% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$40.4B
| $751M | 15.47% |
14,951,660
+6,679,082
| +81% | +$356M |
|
|
2
Amazon
AMZN
$2.44T
| $344M | 7.1% |
9,624,860
+9,608,860
| +60,055% | +$325M |
|
|
3
Broadcom
AVGO
$1.76T
| $223M | 4.58% |
+14,318,500
| New | +$218M |
|
4
Microsoft
MSFT
$2.9T
| $222M | 4.58% |
4,346,860
+1,386,660
| +47% | +$72.1M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $215M | 4.42% |
2,176,000
+591,500
| +37% | +$61.2M |
|
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $183M | 3.78% |
875,100
+765,100
| +696% | +$159M |
|
|
7
Constellation Brands
STZ
$22.5B
| $174M | 3.58% |
1,051,500
+992,500
| +1,682% | +$155M |
|
|
MON
8
DELISTED
Monsanto Co
MON
| $170M | 3.5% |
+1,644,000
| New | +$163M |
|
|
9
Charter Communications
CHTR
$17.3B
| $169M | 3.49% |
740,942
-712,047
| -49% | -$153M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $163M | 3.37% |
707,456
-896,736
| -56% | -$207M |
|
|
TSG
11
DELISTED
The Stars Group Inc.
TSG
| $123M | 2.54% |
8,058,235
+653,048
| +9% | +$8.99M |
|
12
Pampa Energía
PAM
$4.57B
| $121M | 2.49% |
4,426,903
| – | – |
|
13
VanEck Gold Miners ETF
GDX
$22.5B
| $116M | 2.4% |
4,201,700
+3,355,979
| +397% | +$80.6M |
|
14
Union Pacific
UNP
$174B
| $115M | 2.37% |
+1,320,200
| New | +$112M |
|
15
Alphabet (Google) Class A
GOOGL
$4.12T
| $112M | 2.3% |
3,171,820
+1,702,320
| +116% | +$62.5M |
|
|
MON
16
CALL
DELISTED
Monsanto Co
MON
| $100M | 2.06% |
+969,000
| New | +$96M |
|
|
SWN
17
DELISTED
Southwestern Energy Company
SWN
| $96.4M | 1.99% |
7,666,753
+4,512,453
| +143% | +$54.7M |
|
|
CTRA
18
DELISTED
Coterra Energy
CTRA
| $96.3M | 1.98% |
3,742,000
+2,580,000
| +222% | +$61.9M |
|
|
CPN
19
DELISTED
Calpine Corporation
CPN
| $90.8M | 1.87% |
6,159,194
+3,927,694
| +176% | +$58.2M |
|
20
Comcast
CMCSA
$87.3B
| $87.5M | 1.8% |
2,682,938
-903,800
| -25% | -$28.1M |
|
|
EGN
21
DELISTED
Energen
EGN
| $77.1M | 1.59% |
+1,599,900
| New | +$69.6M |
|
22
Ovintiv
OVV
$17B
| $62.2M | 1.28% |
1,597,760
+1,304,820
| +445% | +$47.8M |
|
|
DYN
23
DELISTED
Dynegy, Inc.
DYN
| $61.3M | 1.26% |
3,554,629
+3,447,229
| +3,210% | +$59.9M |
|
|
ENDP
24
DELISTED
Endo International plc
ENDP
| $56.8M | 1.17% |
+3,640,700
| New | +$75.4M |
|
25
Range Resources
RRC
$9.33B
| $52.6M | 1.08% |
1,218,500
+1,176,600
| +2,808% | +$48.2M |
|
Similar funds
CIP
IMRF
SF
CMTU
PGFC
EGM
PA
MT
PointState Capital's Q2 2016 Portfolio in Review
As of Q2 2016, PointState Capital held 153 positions worth $4.85B, up 31% from $3.71B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
PointState Capital deployed $1.07B of net new capital in Q2 2016, opening 63 new positions and adding to 23 existing holdings. Its largest new stake was Broadcom: 14,318,500 shares worth $223M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 38% a quarter earlier, followed by Energy and Communication Services.
On the sell side, the largest reduction was Allergan plc, an estimated $207M trimmed.
- PointState Capital's largest Q2 2016 buy was Broadcom: 14,318,500 shares worth $223M.
- PointState Capital added most to Teva Pharmaceuticals in Q2 2016, an estimated $356M increase.
- PointState Capital's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $207M.
- PointState Capital fully exited LyondellBasell Industries in Q2 2016, selling an estimated $371M.
- PointState Capital's ten largest holdings make up 54% of its $4.85B portfolio in Q2 2016.
- PointState Capital opened 63 new positions and closed 45 in Q2 2016.
- PointState Capital's portfolio value rose 31% quarter-over-quarter to $4.85B.
Based on PointState Capital's 13F filing for Q2 2016, filed 15 Aug 2016.